Home › Compare › EMOR vs PLD

EMOR vs PLD: Dividend Comparison 2026

EMOR yields 5000.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMOR wins by $62217131802818.84M in total portfolio value
10 years
EMOR
EMOR
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full EMOR calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — EMOR vs PLD

📍 EMOR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMORPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMOR + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMOR pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMOR
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, EMOR beats the other by $50,882,683,244,267,010,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMOR + PLD for your $10,000?

EMOR: 50%PLD: 50%
100% PLD50/50100% EMOR
Portfolio after 10yr
$31108565901415.93M
Annual income
$29,930,990,143,691,735,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

EMOR
No analyst data
Altman Z
-337.8
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMOR buys
0
PLD buys
0
No recent congressional trades found for EMOR or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMORPLD
Forward yield5000.00% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$62217131802825.35M ✓$6.50M
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$5,256,436.18
Total dividends collected$62057786341622.61M ✓$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMOR vs PLD ($10,000, DRIP)

YearEMOR PortfolioEMOR Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$510,700$500,000.00$11,255$555.24+$499.4K → EMOR
2$24,410,935$23,864,485.98$13,062$1,018.59+$24.40M → EMOR
3$1,092,192,501$1,066,072,800.30$15,903$1,926.67+$1092.18M → EMOR
4$45,746,366,951$44,577,720,975.17$20,839$3,823.32+$45746.35M → EMOR
5$1,793,932,828,410$1,744,984,215,772.56$30,464$8,166.08+$1793932.80M → EMOR
6$65,871,973,805,320$63,952,465,678,921.49$52,054$19,457.30+$65871973.75M → EMOR
7$2,265,146,887,602,700$2,194,663,875,631,007.20$109,886$54,188.93+$2265146887.49M → EMOR
8$72,954,689,148,998,180$70,530,981,979,263,280.00$304,030$186,451.18+$72954689148.69M → EMOR
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$1,166,125$840,813.32+$2201076182659.72M → EMOR
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$6,504,190$5,256,436.18+$62217131802818.84M → EMOR

EMOR vs PLD: Complete Analysis 2026

EMOR — Stock

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Full EMOR Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this EMOR vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMOR vs SCHDEMOR vs JEPIEMOR vs OEMOR vs KOEMOR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.